04
February
2020
Lowey Dannenberg Is Investigating Allakos, Inc.
Lowey Dannenberg is investigating Allakos, Inc. (“Allakos” or the “Company”) (NASDAQ: ALLK) and certain of its officers and/or directors for potential violation of federal securities laws or other unlawful business practices in connection with Allakos’ development of AK002, a drug for the treatment of certain gastrointestinal diseases. On December 18, 2019, Seligman Investments (“Seligman”), an investment management company, published a…
Read More
